Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge
- PMID: 34731553
- PMCID: PMC8609569
- DOI: 10.1056/NEJMc2115597
Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge
Update of
-
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge.medRxiv [Preprint]. 2021 Sep 22:2021.09.17.21263624. doi: 10.1101/2021.09.17.21263624. medRxiv. 2021. Update in: N Engl J Med. 2021 Dec 23;385(26):2485-2487. doi: 10.1056/NEJMc2115597. PMID: 34611666 Free PMC article. Updated. Preprint.
References
-
- Nasreen S, Chung H, He S, et al. Effectiveness of COVID-19 vaccines against variants of concern in Ontario, Canada. July 16, 2021. (https://www.medrxiv.org/content/10.1101/2021.06.28.21259420v2#:~:text=Fu...). preprint.
-
- Centers for Disease Control and Prevention. COVID data tracker: variant proportions, 2021. (https://covid.cdc.gov/covid-data-tracker/#variant-proportions).
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources